AU2010241549A1 - Blood parasiticide - Google Patents

Blood parasiticide Download PDF

Info

Publication number
AU2010241549A1
AU2010241549A1 AU2010241549A AU2010241549A AU2010241549A1 AU 2010241549 A1 AU2010241549 A1 AU 2010241549A1 AU 2010241549 A AU2010241549 A AU 2010241549A AU 2010241549 A AU2010241549 A AU 2010241549A AU 2010241549 A1 AU2010241549 A1 AU 2010241549A1
Authority
AU
Australia
Prior art keywords
acid
vitamin
formulations
formulation
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2010241549A
Other languages
English (en)
Inventor
Rogerio Artacho
Renato B. Ferreira
Joao Marcelo C. Gomes
Luis F. Vettorato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of AU2010241549A1 publication Critical patent/AU2010241549A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2010241549A 2009-05-01 2010-04-29 Blood parasiticide Abandoned AU2010241549A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17481109P 2009-05-01 2009-05-01
US61/174,811 2009-05-01
PCT/US2010/032923 WO2010127081A1 (fr) 2009-05-01 2010-04-29 Antiparasitaire sanguin

Publications (1)

Publication Number Publication Date
AU2010241549A1 true AU2010241549A1 (en) 2011-11-03

Family

ID=42262653

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010241549A Abandoned AU2010241549A1 (en) 2009-05-01 2010-04-29 Blood parasiticide

Country Status (12)

Country Link
US (1) US20120129801A1 (fr)
JP (1) JP2010260864A (fr)
AR (1) AR076520A1 (fr)
AU (1) AU2010241549A1 (fr)
BR (1) BRPI1014370A2 (fr)
CL (1) CL2011002651A1 (fr)
CO (1) CO6450623A2 (fr)
MX (1) MX2011011559A (fr)
TW (1) TW201043231A (fr)
UY (1) UY32596A (fr)
WO (1) WO2010127081A1 (fr)
ZA (1) ZA201107630B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
CN103896843B (zh) * 2014-04-17 2016-02-24 山东久隆精细化工有限公司 一种咪唑苯脲的制备方法
WO2016071446A1 (fr) * 2014-11-06 2016-05-12 Bimeda Amea Limited Formulation injectable à usage vétérinaire
CN107334731B (zh) * 2017-07-07 2021-06-04 中国农业科学院饲料研究所 一种牛用二丙酸咪唑苯脲注射液及其制备方法和应用
WO2022053584A1 (fr) * 2020-09-14 2022-03-17 Bimeda Amea Limited Formulation injectable vétérinaire optimisée

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053593A (en) * 1975-11-26 1977-10-11 Lew Frumoff Medical product combining antimicrobial, antiporasitic and vitamin complex
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation

Also Published As

Publication number Publication date
US20120129801A1 (en) 2012-05-24
CL2011002651A1 (es) 2012-05-25
JP2010260864A (ja) 2010-11-18
UY32596A (es) 2010-06-30
MX2011011559A (es) 2011-11-18
WO2010127081A1 (fr) 2010-11-04
ZA201107630B (en) 2012-07-25
AR076520A1 (es) 2011-06-15
CO6450623A2 (es) 2012-05-31
TW201043231A (en) 2010-12-16
BRPI1014370A2 (pt) 2016-04-05

Similar Documents

Publication Publication Date Title
US20120129801A1 (en) Blood parasiticide
US20080318330A1 (en) Method of standardization of bacterial polysaccharides found in rumen fluid
RU2521369C1 (ru) Препарат для стимуляции обменных процессов, профилактики и лечения желудочно-кишечных заболеваний телят в ранний постнатальный период
WO2011034464A1 (fr) Forme pharmaceutique injectable pour le traitement de l&#39;ictus ischémique aigu et du traumatisme crânien, son procédé de fabrication et d&#39;utilisation
US20110106053A1 (en) Treatment apparatus
RU2351323C2 (ru) Способ получения комплексного препарата для профилактики и лечения нарушений обмена веществ, микроэлементозов, повышения резистентности организма животных
EP1945223B1 (fr) Compositions de cefquinome et procédés d&#39;utilisation de celles-ci
RU2442573C1 (ru) Способ лечения дизентерии свиней
MX2012009914A (es) Terapia oral de b12.
AU2016210773B2 (en) An anti-parasitic formulation and a method for treating parasitic infestations in an animal
EP2905013B1 (fr) Traitement de la fièvre de la côte orientale
US5561131A (en) Defaunation method
US20220387433A1 (en) Type v phosphodiesterase inhibitor compositions, methods of making them and methods of using them in preventing or treating elevated pulmonary vascular pressure or pulmonary hemorrhages
US20220175707A1 (en) Pregabalin formulations and use thereof
RU2342122C1 (ru) Лекарственное средство для лечения диареи у телят
RU2395278C1 (ru) Способ получения комплексного препарата для профилактики и лечения патологий обмена веществ и нарушений функций иммунной системы животных
EP0238207A1 (fr) Mélanges bactéricides
RU2404728C1 (ru) Способ повышения общей резистентности организма, профилактики и лечения респираторных, желудочно-кишечных и гинекологических заболеваний, профилактики эмбриональной смертности у животных и лекарственное средство для его осуществления
US20190282613A1 (en) Injection composition comprising an iron dextran complex and vitamins for preventing and treating anemia
RU2678082C1 (ru) Способ лечения свиней при дизентерии и других бактериальных заболеваниях
EP0112061A2 (fr) Composition pharmaceutique et vétérinaire contenant du guanoxabenz
AU2021409640A1 (en) Parenteral cannabinoid formulations and uses thereof
Gaur et al. Evaluation of hematological and biochemical values after repeated co-administration of moxifloxacin and flunixin in goats.
EA031933B1 (ru) Ветеринарный биопрепарат, способ его получения (варианты) и способ лечения нодулярного дерматита крупного рогатого скота (варианты)
EA019956B1 (ru) Фармацевтическая композиция для лечения заболеваний бактериальной и микоплазменной этиологии

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application